CNSX:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis → Buy Friday. Sell Monday. (From WealthPress) (Ad) Free IMCC Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get IM Cannabis alerts: Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About IM Cannabis Stock (CNSX:IMCC)IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.Read More Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover IMCC Stock News HeadlinesMay 8, 2024 | uk.investing.comIm Cannabis Corp (IMCC)April 16, 2024 | finanznachrichten.deIM Cannabis Corp.: IMC to transfer its Oranim Pharmacy shares back to the sellerApril 16, 2024 | finance.yahoo.comIMC to transfer its Oranim Pharmacy shares back to the sellerApril 4, 2024 | yahoo.comMarijuana decriminalization bill runs into opposition, remains aliveMarch 28, 2024 | markets.businessinsider.comIMCC Stock Earnings: IM Cannabis Misses EPS, Misses Revenue for Q4 2023February 12, 2024 | msn.comNew York medical cannabis bills in legislature aim for reciprocity, nixing excise taxesJanuary 31, 2024 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price RuleJanuary 31, 2024 | finance.yahoo.comIM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price RuleDecember 8, 2023 | msn.comWar In Gaza Forces Israel To Delay Medical Cannabis ReformNovember 13, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Reports Third Quarter 2023 Financial ResultsNovember 13, 2023 | finance.yahoo.comIM Cannabis Reports Third Quarter 2023 Financial ResultsSeptember 19, 2023 | finance.yahoo.comIM Cannabis Announces CFO DepartureAugust 28, 2023 | finance.yahoo.comIs IM Cannabis (IMCC) Too Good to Be True? A Comprehensive Analysis of a Potential Value TrapAugust 11, 2023 | markets.businessinsider.comThese Companies Are Ready To Capitalize On Latest Marijuana Reforms In Israel And GermanyAugust 4, 2023 | marketwatch.comIM Cannabis Notified Over Lack of Compliance with Nasdaq Listing RequirementsAugust 1, 2023 | msn.comLocal cannabis dispensary chain shut down amid crackdownJuly 13, 2023 | benzinga.com'GOP-Controlled House Committee Blocks Every Marijuana And Psychedelics Amendment To Defense Bill From Getting Floor Vote' - Marijuana MomentJune 13, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price RequirementJune 13, 2023 | msn.comIM Cannabis regains compliance with Nasdaq's minimum bid price requirementJune 13, 2023 | finance.yahoo.comIM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price RequirementMay 15, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Reports First Quarter 2023 Financial Results; Gross Profit Increased 46% Year-over-YearMay 15, 2023 | finance.yahoo.comIM Cannabis Reports First Quarter 2023 Financial Results; Gross Profit Increased 46% Year-over-YearMay 8, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Completes Debt Settlement with L5 CapitalMay 8, 2023 | finance.yahoo.comIM Cannabis Completes Debt Settlement with L5 CapitalMay 8, 2023 | finance.yahoo.comIM Cannabis to Report First Quarter 2023 Financial Results on Monday, May 15 at 9:00am ETSee More Headlines Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:IMCC CUSIPN/A CIKN/A Webwww.imcannabis.com Phone972 7 7444 2333FaxN/AEmployees95Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Marc Lustig M.B.A. (Age 50)M.Sc., Executive Chairman Comp: $129.92kMr. Oren ShusterCEO & DirectorMr. Uri Birenberg (Age 48)Chief Financial Officer Comp: $325.71kMr. Richard BallaChief Executive Officer of AdjupharmAdvocate Michal Lebovitz NissimovGeneral CounselKey CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBio-Rad LaboratoriesCNSX:BIOBlueberries MedicalCNSX:BBMView All Competitors IMCC Stock Analysis - Frequently Asked Questions How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:IMCC) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.